Lipella Pharmaceuticals Inc. (LIPO) NASDAQ

0.20

+0.029(+16.96%)

Updated at January 13 01:38PM

Currency In USD

Valuation

Market Cap3.2M
Enterprise Value1.06M
P/E Ratio-0
PEG Ratio-0
Price/Sales Ratio5.32
Price/Book Ratio0
Enterprise/Revenue-9,159.9
Enterprise/EBITDA1.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-7,244.67
Operating Margin-7,361.3

Management Effectiveness

Return On Assets-0.54
Return On Equity-3.36

Income Statement

Revenue536,357
Revenue/Share0.04
Gross Profit-3.08M
EBITDA-5.01M
Net Income-5.02M
Diluted EPS-4.79

Balance Sheet

Total Cash1.86B
Total Cash/Share407.94
Total Debt264.08M
Total Debt/Equity0.18
Current Ratio3.24
Book Value Per Share327.01

Price History

52-Week Change-93.44
52-Week High7.31
52-Week Low0.17
Moving Average 50 Days0.32
Moving Average 200 Days1.14

Statistics

Average Volume11,280
Shares Outstanding4.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:8
Last Split DateNovember 08, 2024